These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1424856)

  • 1. Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life.
    van Schayck CP; Rutten-van Mölken MP; van Doorslaer EK; Folgering H; van Weel C
    Chest; 1992 Nov; 102(5):1384-91. PubMed ID: 1424856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of an inhaled steroid on quality of life in patients with asthma or COPD.
    van Schayck CP; Dompeling E; Rutten MP; Folgering H; van den Boom G; van Weel C
    Chest; 1995 May; 107(5):1199-205. PubMed ID: 7750306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
    Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
    Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L; de Muralt B; Schutz Y; Fitting JW
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
    Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
    D'Urzo AD; De Salvo MC; Ramirez-Rivera A; Almeida J; Sichletidis L; Rapatz G; Kottakis J;
    Chest; 2001 May; 119(5):1347-56. PubMed ID: 11348938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
    Rennard SI; Serby CW; Ghafouri M; Johnson PA; Friedman M
    Chest; 1996 Jul; 110(1):62-70. PubMed ID: 8681667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
    Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
    Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
    Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
    Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
    Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
    JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
    Curzon PG; Martin MA; Cooke NJ; Muers MF
    Thorax; 1983 Aug; 38(8):601-4. PubMed ID: 6225214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.